| Address :215 BIRCHWOOD AVE CRANFORD, NJ, 07016-0540 UNITED STATES | |||
| Status : H | Type : A | Woman Owned : N | Business Type : N |
| Business Size : E | Primary Business : J | CAO Code : S3101A | ADP Code : HQ0337 |
| Manufacturer: Schering Plough Ltd | |||
Do you need to source NSN parts with the part number such as REBETRON 600, NDC11523-7160-08, NDC11523-7160-02 or any other under CAGE Code 1F095? ASAP Purchasing, owned and operated by ASAP Semiconductor, is an industry-leading NSN parts distributor from top NSN parts manufacturer such as Schering Plough Ltd. We aim to make your parts procurement process as fast and simple as possibly by allowing customers to search our inventory through our easy to use search engine.
NSN parts under CAGE Code 1F095 of Schering Plough Ltd is in stock and ready to ship from ASAP Purchasing. We have a large inventory of over 6 billion parts. We guarantee we will have the part you need in our ready-to-ship inventory. Fill out our request for quote form to get connected to one of our dedicated sales representatives.
Manufacturer for CAGE Code 1F095
Part Numbers List for CAGE Code 1F095
| Part No | NSN | Item Name | QTY | RFQ |
|---|---|---|---|---|
| REBETRON 600 | 6505-01-497-7883 | ribavirin and interferon combination pack | Avl | RFQ |
| NDC11523-7160-08 | 6505-01-524-9179 | loratadine tablets | Avl | RFQ |
| NDC11523-7160-02 | 6505-01-505-0915 | loratadine tablets | Avl | RFQ |
| NDC00085-4110-03 | 6505-01-388-2487 | isosorbide mononitrate extended release tablets | Avl | RFQ |
| NDC00085-4110-01 | 6505-01-383-7339 | isosorbide mononitrateextended release tablets | Avl | RFQ |
| NDC00085-3320-35 | 6505-01-357-5372 | nitroglycerin transdermal system | Avl | RFQ |
| NDC00085-3320-35 | 6505-01-157-9064 | nitroglycerin trans | Avl | RFQ |
| NDC00085-3320-30 | 6505-01-157-9064 | nitroglycerin trans | Avl | RFQ |
| NDC00085-3320-30 | 6505-01-237-5373 | nitroglycerin trans | Avl | RFQ |
| NDC00085-3315-35 | 6505-01-357-5373 | nitroglycerin trans | Avl | RFQ |
| NDC00085-3305-35 | 6505-01-357-5370 | nitroglycerin transdermal system | Avl | RFQ |
| NDC00085-1777-01 | 6505-01-492-8089 | ciprofloxacin oral | Avl | RFQ |
| NDC00085-1737-01 | 6505-01-503-7443 | moxifloxacin hydroc | Avl | RFQ |
| NDC00085-1236-03 | 6505-01-497-7883 | ribavirin and interferon combination pack | Avl | RFQ |
| NDC00085-1179-02 | 6505-01-366-7515 | interferon alpha 2b recombinant for injection | Avl | RFQ |
| NDC00085-1133-01 | 6505-01-377-1460 | interferon alpha 2b recombinant injection | Avl | RFQ |
| NDC00085-1132-01 | 6505-01-538-2871 | albuterol sulfate i | Avl | RFQ |
| NDC00085-0933-10 | 6505-01-070-0821 | theophylline extend | Avl | RFQ |
| NDC00085-0924-02 | 6505-01-243-5901 | clotrimazole and be | Avl | RFQ |
| NDC00085-0819-35 | 6505-01-409-2737 | nitroglycerin transdermal system | Avl | RFQ |
| NDC00085-0819-35 | 6505-01-396-1314 | nitroglycerin transdermal system | Avl | RFQ |
| NDC00085-0819-30 | 6505-01-409-2737 | nitroglycerin transdermal system | Avl | RFQ |
| NDC00085-0806-01 | 6505-01-272-5114 | theophylline extend | Avl | RFQ |
| NDC00085-0787-81 | 6505-01-266-8634 | potassium chloride | Avl | RFQ |
| NDC00085-0787-06 | 6505-01-318-5737 | potassium chloride extended release tablets usp | Avl | RFQ |
| NDC00085-0787-01 | 6505-01-266-8634 | potassium chloride | Avl | RFQ |
| NDC00085-0752-08 | 6505-01-319-5117 | labetalol hydrochloride tablets usp | Avl | RFQ |
| NDC00085-0752-07 | 6505-01-319-6667 | labetalol hydrochloride tablets usp | Avl | RFQ |
| NDC00085-0728-01 | 6505-01-233-1901 | betamethasone dipro | Avl | RFQ |
| NDC00085-0720-08 | 6505-01-296-3183 | perphenazine and am | Avl | RFQ |
| NDC00085-0720-04 | 6505-01-028-1189 | perphenazine and am | Avl | RFQ |
| NDC00085-0705-04 | 6505-01-217-1242 | perphenazine tablets usp | Avl | RFQ |
| NDC00085-0691-02 | 6505-01-435-9294 | ceftibuten capsules | Avl | RFQ |
| NDC00085-0647-05 | 6505-01-349-3539 | interferon alpha 2b recombinant for injection | Avl | RFQ |
| NDC00085-0614-02 | 6505-01-116-9245 | albuterol inhalation aerosol | Avl | RFQ |
| NDC00085-0598-08 | 6505-01-299-9141 | perphenazine and am | Avl | RFQ |
| NDC00085-0598-04 | 6505-01-342-9196 | perphenazine and amitriptyline hydrochloride table | Avl | RFQ |
| NDC00085-0584-81 | 6505-01-073-1552 | theophylline extend | Avl | RFQ |
| NDC00085-0584-01 | 6505-01-037-5607 | theophylline extend | Avl | RFQ |
| NDC00085-0571-06 | 6505-01-366-7515 | interferon alpha 2b recombinant for injection | Avl | RFQ |
| NDC00085-0571-02 | 6505-01-246-3792 | interferon alpha 2b recombinant for injection | Avl | RFQ |
| NDC00085-0567-02 | 6505-01-269-6728 | mometasone furoate | Avl | RFQ |
| NDC00085-0567-01 | 6505-01-270-5963 | mometasone furoate | Avl | RFQ |
| NDC00085-0566-05 | 6505-00-904-2190 | betamethasone sodiu | Avl | RFQ |
| NDC00085-0539-01 | 6505-01-351-9262 | interferon alpha 2b recombinant for injection | Avl | RFQ |
| NDC00085-0525-06 | 6505-01-377-1443 | flutamide capsules usp | Avl | RFQ |
| NDC00085-0525-05 | 6505-01-317-0302 | flutamide capsules | Avl | RFQ |
| NDC00085-0525-04 | 6505-01-306-1728 | flutamide capsules | Avl | RFQ |
| NDC00085-0525-03 | 6505-01-329-6495 | flutamide capsules usp | Avl | RFQ |
| NDC00085-0517-04 | 6505-01-269-6738 | betamethasone dipro | Avl | RFQ |
